Stifel lowered the firm’s price target on Bolt Biotherapeutics (BOLT) to $1.25 from $1.50 and keeps a Hold rating on the shares. Completion of ...

Bolt Biotherapeutics (NASDAQ:BOLT – Get Free Report)‘s stock had its “neutral” rating restated by equities researchers at HC ...

智通财经APP获悉，据知情人士透露，优步(UBER.US)的竞争对手Bolt Technology OU正与顾问合作PJT Partners，探讨可能的方案，包括首次公开发募股(IPO)。

BDC-4182 on track to start a clinical trial in gastric cancer in second quarter 2025BDC-3042 Phase 1 clinical trial fully enrolled the highest ...

Bolt Biotherapeutics (NASDAQ:BOLT – Get Free Report) had its price objective lowered by stock analysts at Stifel Nicolaus ...

REDWOOD CITY, Calif. (AP) — REDWOOD CITY, Calif. (AP) — Bolt Biotherapeutics Inc. (BOLT) on Monday reported a loss of $15.9 million in its fourth quarter. The Redwood City, California-based ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Bolt Projects Holdings, Inc., an industrial organic chemicals firm, has been notified by The Nasdaq Stock Market LLC of a potential delisting due to non-compliance with market value requirements.